Markets:

Overview

News

Currencies

International

Treasuries

Madrigal Pharmaceuticals, Inc. - Common Stock (NQ:MDGL)

553.48 UNCHANGED

Streaming Delayed Price Updated: 4:00 PM EDT, Jul 17, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Madrigal Pharmaceuticals, Inc. - Common Stock

< Previous 1 2 3 4 5 6 7 8 9 10 Next >

Stock Market Falls Sharply Again As Tesla Dives, Micron Hits Chips; Nike, FedEx Strong: Weekly Review ↗

December 23, 2022

The market uptrend is under pressure.

Via Investor's Business Daily

Universal Health Services, Madrigal Pharmaceuticals And These Overbought Majors In The Healthcare Sector ↗

December 23, 2022

The most overbought stocks in the healthcare sector presents an opportunity to go short on these overvalued companies.

Via Benzinga

Why Madrigal Pharmaceuticals Was a Top Stock This Week ↗

December 23, 2022

Biotech bulls stampeded the company following its latest clinical update.

Via The Motley Fool

7 Drug Stocks That Will Soar in 2023 ↗

December 22, 2022

These drug stocks to buy look poised to generate huge profits for investors in 2023 and in subsequent years.

Via InvestorPlace

Earnings Optimism Puts Wind In Wall Street's Sails ↗

December 21, 2022

The major indexes are extending their rally off a mid-December losing streak.

Via Talk Markets

Analyst Ratings for Madrigal Pharmaceuticals ↗

December 20, 2022

Via Benzinga

Madrigal Shares Skyrocket After Successful NASH Study ↗

December 19, 2022

Via Benzinga

Why Did Viking Therapeutics Stock Skyrocket

December 21, 2022

VKTX stock is young but strong and they have excellent potential, particularly following successful trial results from Madrigal Pharma's recent drug trial.

Via MarketBeat

Top M&A Target: Madrigal Pharmaceuticals Could Be Next After Successful NASH Data, Analyst Says ↗

December 20, 2022

Via Benzinga

Madrigal Pharmaceuticals Gets Price Target Bumps By Analysts Following Successful NASH Study ↗

December 20, 2022

Madrigal Pharmaceuticals Inc (NASDAQ: MDGL) announced positive topline results from the pivotal Phase 3 MAESTRO-NASH biopsy trial of resmetirom. Madrigal Pharmaceuticals shares jumped 268.1% to close...

Via Benzinga

Peering Into Madrigal Pharmaceuticals's Recent Short Interest ↗

December 20, 2022

Madrigal Pharmaceuticals's (NASDAQ:MDGL) short percent of float has risen 3.82% since its last report. The company recently reported that it has 2.16 million shares sold short, which is 15.49% of all...

Via Benzinga

Tesla To $285? Here Are 10 Other Price Target Changes For Tuesday ↗

December 20, 2022

Wells Fargo raised Ross Stores, Inc. (NASDAQ: ROST) price target from $120 to $135. Wells Fargo analyst Ike Boruchow maintained an Overweight rating on the stock. Ross Stores shares fell 0.9% to close...

Via Benzinga

Here's How An Options Trader Made $5.5 Million In One Day ↗

December 20, 2022

Madrigal Pharmaceuticals Inc (NASDAQ: MDGL) shares rose sharply on Monday after the company announced positive topline results from the pivotal Phase 3 MAESTRO-NASH (fatty liver disease)

Via Benzinga

Tesla, Amazon, Apple, Madrigal, Walt Disney: Why These 5 Stocks Are Drawing Investors' Attention Today ↗

December 19, 2022

Major Wall Street indices closed in the red on Monday as investor optimism on the much-anticipated Santa Claus rally began to fade over fears of recession gaining momentum.

Via Benzinga

Healthcare Portfolio Is Doing Well But Biotech Stocks Are Mired In Macro ↗

December 19, 2022

The biotech sector has not done well in 2022 despite some strong runs. Small and mid-cap stocks are more “risk-off’ with interest rates rising and sentiment waning.

Via Talk Markets

Madrigal Pharmaceuticals (NASDAQ: MDGL) Reports Impressive Topline Results from Phase 3 Trial of Resmetirom to Treat NASH and Liver Fibrosis

December 19, 2022

Madrigal Pharmaceuticals, Inc. (NASDAQ: MDGL) is engaged as a clinical-stage biopharmaceutical company, which is focused on the research and development

Via Spotlight Growth

Why Cosmos Health Shares Are Trading Lower By Around 60%? Here Are 79 Stocks Moving In Monday's Mid-Day Session ↗

December 19, 2022

Gainers Madrigal Pharmaceuticals, Inc. (NASDAQ: MDGL) shares jumped 259% to $229.35 after the company announced resmetirom achieved both primary endpoints in NASH and liver fibrosis trial.

Via Benzinga

Dow Struggles To Maintain Morning Gains ↗

December 19, 2022

This morning's rally was short-lived, and by midday, the major indexes were trading back in the red amid looming recession anxieties.

Via Talk Markets

12 Health Care Stocks Moving In Monday's Intraday Session ↗

December 19, 2022

Via Benzinga

Why Madrigal Pharmaceuticals Stock Is Crushing It Today ↗

December 19, 2022

The company reported stellar late-stage clinical trial results for its experimental NASH (nonalcoholic steatohepatitis) drug.

Via The Motley Fool

Madrigal Pharmaceuticals, Cerevel Therapeutics And Some Other Big Stocks Moving Higher On Monday ↗

December 19, 2022

U.S. stocks traded mixed, with the Nasdaq Composite dropping around 90 points on Monday. Here are some big stocks recording gains in today’s session.

Via Benzinga

Tesla's Bouncing, but This Nasdaq Stock Tripled Monday Morning ↗

December 19, 2022

Good news can come in different forms.

Via The Motley Fool

Why Is Viking Therapeutics (VKTX) Stock Up 67% Today? ↗

December 19, 2022

Viking Therapeutics (VKTX) stock is taking off on Monday with heavy trading without any news from the biopharmaceutical company.

Via InvestorPlace

AJRD Stock Alert: What to Know as L3Harris Technologies Acquires Aerojet Rocketdyne ↗

December 19, 2022

Aerojet Rocketdyne (AJRD) stock is on the move today as investors react to a $4.7 billion deal with L3Harris Technologies (LHX).

Via InvestorPlace

Madrigal Pharmaceuticals Stock Is Up 200% In One Day, Here's Why

December 19, 2022

Madrigal Pharmaceuticals announced positive results for a major clinical trial and shares are up more than 200% because of it.

Via MarketBeat

Why Viking Therapeutics Stock Is Moving Alongside Madrigal Pharmaceuticals Shares Today ↗

December 19, 2022

Viking Therapeutics Inc (NASDAQ: VKTX) shares are trading higher Monday, in sympathy with Madrigal Pharmaceuticals Inc (NASDAQ: MDGL), which announced a suc

Via Benzinga

Why Is Madrigal Pharmaceuticals (MDGL) Stock Up 216% Today? ↗

December 19, 2022

Madrigal Pharmaceuticals (MDGL) stock is rocketing higher on Monday after sharing positive results from its NASH treatment.

Via InvestorPlace

Madrigal Pharma Stock Triples After Knocking NASH Study Out Of The Park ↗

December 19, 2022

The company hit both of its goals in a Phase 3 study of a pill for the liver disease.

Via Investor's Business Daily

12 Health Care Stocks Moving In Monday's Pre-Market Session ↗

December 19, 2022

Via Benzinga

Tesla, Amazon, Madrigal Pharma, Pfizer, Synaptogenix: Why These 5 Stocks Are Drawing Investors' Attention Today ↗

December 18, 2022

Major Wall Street indices had closed in the red on Friday in the wake of a continued sell-off following the hawkish stance asserted by the Federal Reserve. Friday witnessed volatile trading as a large...

Via Benzinga

< Previous 1 2 3 4 5 6 7 8 9 10 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.